The Expanding Field of Zinc Supplementation in Children

  • P. Walravens

Abstract

The determination of zinc deficiency still remains elusive, as there is no single, sensitive index that will provide an accurate answer. Therefore, as suggested by Aggett (1), consideration of known factors that lead to zinc deficiency, a judicious selection of laboratory tests and the clinical or biochemical response to zinc supplements remain the basis of the diagnosis. In controlled studies during the childhood years, a positive growth response to zinc supplements is considered the correction of a pre-existing deficiency state. Thus simple, careful measurements may confirm an existing deficiency and are sometimes more useful than various biochemical assays which have been measured in the quest of defining zinc deficiency. When the many factors that influence plasma zinc concentrations and the limitations of hair zinc levels became known, a broad spectrum of functional indices were examined to include a host of zinc metalloenzymes in plasma, erythrocytes and leukocytes, apothymulin levels in serum and white blood cell chemotaxis. Variations in taste acuity and adaptation to darkness, and measurements of cutaneous hypersensitivity are additional functional indices which are sometimes used to monitor responses to zinc supplements.

Keywords

Zinc Deficiency Zinc Supplement Hair Zinc Exocrine Pancreatic Insufficiency Acrodermatitis Enteropathica 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    P.J. Aggett, in Trace Elements in Infancy and Childhood. Annales Nestlé, 52, 94–106 (1994).Google Scholar
  2. 2.
    C.J. Bates, P.H. Evans, M. Dardenne, A. Prentice et al., Br. J. Nutr., 69, 243–255 (1993).CrossRefGoogle Scholar
  3. 3.
    H. Friis, T. Ndhloyu, K. Mduluza, K. Kaondera et al., Faseb J. A164 (1984).Google Scholar
  4. 4.
    K.R. Cavan, R.S. Gibson, CF. Grazioso, A.M. Isalgue AM et al., Am. J. Clin. Nutr. 37, 344–352 (1993).Google Scholar
  5. 5.
    RA. Walravens, A. Chakar, R. Mokni, J. Denise, D. Lemonnier, Lancet 340, 683–685 (1993).CrossRefGoogle Scholar
  6. 6.
    N.F. Krebs, J.E. Westcott, N. Butler-Simon, K.M. Hambidge, Faseb J. 10 (1996), abstract.Google Scholar
  7. 7.
    C. Castillo-Duran, A. Rodriguez, G. Venegas, P. Alvarez, G. Icaza, J. Pediatr. 127, 206–211 (1995).CrossRefGoogle Scholar
  8. 8.
    L. Schlesinger, M. Arevala, S. Arredondo, M. Diaz et al.Am. J. Clin. Nutr. 56, 491–498 (1992).Google Scholar
  9. 9.
    M. Ruz, C. Castillo-Duran, X. Lara, A. Rebolledo et al., Faseb J., 9, A736 (1995).Google Scholar
  10. 10.
    C. Castillo-Duran, H. Garcia, R Venegas, I. Torrealba et al., Acta Paediatr. 83, 833–837 (1994).CrossRefGoogle Scholar
  11. 11.
    J. Rivera, K.H. Brown, M.C. Santizo, M. Ruel, B. Lonnerdal. Faseb J. 9, A164 (1995).Google Scholar
  12. 12.
    C. Chen, J. Yang, J. Li, F. Zhao, H. Dayal, H. Sandstead. Faseb J. 9, A481(1995).Google Scholar
  13. 13.
    J.G. Penland, H.H. Sandstead, X. Chen, J. Li. Faseb J., 10 (1996), abstract.Google Scholar
  14. 14.
    S. Sazwal, R.E. Black, M.K. Bhan, N. Bhandari et al., N. Engl. J. Med. 333, 839–844 (1995).CrossRefGoogle Scholar
  15. 15.
    J.L. Dosado, L.H. Allen, R Lopez, H. Martinez, Faseb J., 9, A157 (1995).Google Scholar
  16. 16.
    M.T. Ruel, J. Rivera, K. Brown, M.C. Santizo, B. Lonnerdal, Faseb J. 9, A157 (1995).Google Scholar

Copyright information

© Springer Science+Business Media New York 1996

Authors and Affiliations

  • P. Walravens
    • 1
  1. 1.Barbara Davis Center for Childhood DiseasesUniversity of Colorado Health Sciences CenterDenverUSA

Personalised recommendations